IT201700105213A1 - Metodo per la valutazione quantitativa in biologico, di proteine native e modificate e suo uso - Google Patents

Metodo per la valutazione quantitativa in biologico, di proteine native e modificate e suo uso

Info

Publication number
IT201700105213A1
IT201700105213A1 IT102017000105213A IT201700105213A IT201700105213A1 IT 201700105213 A1 IT201700105213 A1 IT 201700105213A1 IT 102017000105213 A IT102017000105213 A IT 102017000105213A IT 201700105213 A IT201700105213 A IT 201700105213A IT 201700105213 A1 IT201700105213 A1 IT 201700105213A1
Authority
IT
Italy
Prior art keywords
native
biological
quantitative evaluation
modified proteins
proteins
Prior art date
Application number
IT102017000105213A
Other languages
English (en)
Inventor
Massimo Papale
Original Assignee
Fluidia S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fluidia S R L filed Critical Fluidia S R L
Priority to IT102017000105213A priority Critical patent/IT201700105213A1/it
Publication of IT201700105213A1 publication Critical patent/IT201700105213A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
IT102017000105213A 2017-09-20 2017-09-20 Metodo per la valutazione quantitativa in biologico, di proteine native e modificate e suo uso IT201700105213A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102017000105213A IT201700105213A1 (it) 2017-09-20 2017-09-20 Metodo per la valutazione quantitativa in biologico, di proteine native e modificate e suo uso

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000105213A IT201700105213A1 (it) 2017-09-20 2017-09-20 Metodo per la valutazione quantitativa in biologico, di proteine native e modificate e suo uso

Publications (1)

Publication Number Publication Date
IT201700105213A1 true IT201700105213A1 (it) 2019-03-20

Family

ID=61148321

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000105213A IT201700105213A1 (it) 2017-09-20 2017-09-20 Metodo per la valutazione quantitativa in biologico, di proteine native e modificate e suo uso

Country Status (1)

Country Link
IT (1) IT201700105213A1 (it)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011058136A1 (en) * 2009-11-16 2011-05-19 F. Hoffmann-La Roche Ag Calibration reagent and uses thereof
WO2011137389A2 (en) * 2010-04-30 2011-11-03 Fred Hutchinson Cancer Research Center Compositions and methods for reliably detecting and/or measuring the amount of a modified target protein in a sample
WO2012109538A2 (en) * 2011-02-10 2012-08-16 President And Fellows Of Harvard College Surrogates of post-translationally modified proteins and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011058136A1 (en) * 2009-11-16 2011-05-19 F. Hoffmann-La Roche Ag Calibration reagent and uses thereof
WO2011137389A2 (en) * 2010-04-30 2011-11-03 Fred Hutchinson Cancer Research Center Compositions and methods for reliably detecting and/or measuring the amount of a modified target protein in a sample
WO2012109538A2 (en) * 2011-02-10 2012-08-16 President And Fellows Of Harvard College Surrogates of post-translationally modified proteins and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PAMELA GHOSH ET AL: "A specific and sensitive assay for blood levels of glycated CD59: A novel biomarker for diabetes", AMERICAN JOURNAL OF HEMATOLOGY, vol. 88, no. 8, 20 June 2013 (2013-06-20), US, pages 670 - 676, XP055368524, ISSN: 0361-8609, DOI: 10.1002/ajh.23478 *

Similar Documents

Publication Publication Date Title
CY1125392T1 (el) Συνθεσεις και μεθοδοι γλυζυλιωσης πρωτεϊνων
CL2019002264A1 (es) Anticuerpos anti-lag3 radiomarcados para la obtención de imágenes mediante inmuno-pet.
CL2020000281A1 (es) Anticuerpos anti-cd39, composiciones que comprenden anticuerpos anti-cd39 y métodos de uso de anticuerpos anti-cd39
CY1123907T1 (el) Συνθεσεις και μεθοδοι για ρυθμιση αυξητικων παραγοντων
CL2019001483A1 (es) Anticuerpos anti-pd-l1 radiomarcados para imágenes de inmuno-pet.
DK3368555T3 (da) Dobbeltfunktionsproteiner og farmaceutisk sammensætning omfattende disse
DK3676316T3 (da) Flydende sammensætning omfattende biologiske enheder og anvendelser deraf
BR112016017986A2 (pt) anticorpos isolados, ácido nucleico isolado, célula hospedeira, métodos de produção de um anticorpo, de tratamento do câncer, de tratamento de uma doença e de detecção de jagged1 humana em uma amostra biológica, imunoconjugado, formulação farmacêutica e uso do anticorpo
BR112017024899A2 (pt) proteínas de ligação trispecíficas e métodos de uso.
IL274891A (en) Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
JOP20170041B1 (ar) اجسام مضادة ضد vista (b7h5)
IL248299B (en) A method and kit for determining the tissue or cell origin of dna
BR112016016916A8 (pt) uso de um anticorpo que se liga à calicreína plasmática ativa para tratamento de angiodema hereditário (hae)
CL2019001671A1 (es) Anticuerpos específicos para fcrn (divisional solicitud 201601147)
MX375032B (es) Proteínas de unión y métodos para utilizarlas.
IL287543A (en) Compositions and methods for reducing bioburden in chromatography
SI3565828T1 (sl) SIRP1 alfa-41BBL fuzijski protein in postopki za njegovo uporabo
IT201700072994A1 (it) Sistema plurisensoriale adattato per la prevenzione di malattie professionali nell’ambiente di lavoro, e metodo per l’uso del sistema
EP4021944A4 (en) CHIMERIC PROTEINS USEFUL IN AUTO-IMMUNITY
EP3976630A4 (en) Actrii-binding proteins and uses thereof
SI3290441T1 (sl) RGMA-vezavni protein in njegova uporaba
EP3356712A4 (en) MICROFLUIDIC VALVE AND CHIP OR SYSTEM WITH THE MICROFLUIDIC VALVE
EP3902556A4 (en) IN VIVO MANIPULATED CEREBLON PROTEIN
IT201700051294A1 (it) Dispositivo e metodo per la raccolta, la conservazione e/o il trasporto di campioni biologici
EP3964531A4 (en) PROTEIN MOLECULE AND ITS USE